Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 15217928)

1.
2.

c-Jun N-terminal Kinase 2 Regulates Multiple Receptor Tyrosine Kinase Pathways in Mouse Mammary Tumor Growth and Metastasis.

Nasrazadani A, Van Den Berg CL.

Genes Cancer. 2011 Jan;2(1):31-45. doi: 10.1177/1947601911400901.

3.

Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profiling.

Fang B, Haura EB, Smalley KS, Eschrich SA, Koomen JM.

Biochem Pharmacol. 2010 Sep 1;80(5):739-47. doi: 10.1016/j.bcp.2010.03.027. Epub 2010 Mar 31. Review.

4.

Mechanisms for Hsp70 secretion: crossing membranes without a leader.

Mambula SS, Stevenson MA, Ogawa K, Calderwood SK.

Methods. 2007 Nov;43(3):168-75. Review.

5.

Molecular cloning of hMena (ENAH) and its splice variant hMena+11a: epidermal growth factor increases their expression and stimulates hMena+11a phosphorylation in breast cancer cell lines.

Di Modugno F, DeMonte L, Balsamo M, Bronzi G, Nicotra MR, Alessio M, Jager E, Condeelis JS, Santoni A, Natali PG, Nisticò P.

Cancer Res. 2007 Mar 15;67(6):2657-65.

6.

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Moreno-Bueno G, Hardisson D, Calero F, Benítez J, Palacios J.

J Clin Pathol. 2007 Sep;60(9):1006-12. Epub 2006 Nov 14.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk